Skip to main content
PMC home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1970;4:102–109. doi: 10.1136/jcp.s3-4.1.102

Coagulation and fibrinolysis after injury.

P T Flute
PMCID: PMC1519988  PMID: 5293379

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRECHTSEN O. K. The fibrinolytic activity of human tissues. Br J Haematol. 1957 Jul;3(3):284–291. doi: 10.1111/j.1365-2141.1957.tb05798.x. [DOI] [PubMed] [Google Scholar]
  2. AMBRUS C. M., MARKUS G. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. Am J Physiol. 1960 Sep;199:491–494. doi: 10.1152/ajplegacy.1960.199.3.491. [DOI] [PubMed] [Google Scholar]
  3. Allington M. J. Fibrinogen and fibrin degradation products and the clumping of staphylococci by serum. Br J Haematol. 1967 Jul;13(4):550–567. doi: 10.1111/j.1365-2141.1967.tb00763.x. [DOI] [PubMed] [Google Scholar]
  4. Barkhan P. Haematological consequences of major surgery. Br J Haematol. 1969 Sep;17(3):221–224. doi: 10.1111/j.1365-2141.1969.tb01365.x. [DOI] [PubMed] [Google Scholar]
  5. Basu H. K. Fibrinolysis and abruptio placentae. J Obstet Gynaecol Br Commonw. 1969 Jun;76(6):481–496. doi: 10.1111/j.1471-0528.1969.tb05868.x. [DOI] [PubMed] [Google Scholar]
  6. Borowiecki B., Sharp A. A. Trauma and fibrinolysis. J Trauma. 1969 Jun;9(6):522–536. [PubMed] [Google Scholar]
  7. Cash J. D. A new approach to studies of the fibrinolytic enzyme system in man. Am Heart J. 1968 Mar;75(3):424–428. doi: 10.1016/0002-8703(68)90100-2. [DOI] [PubMed] [Google Scholar]
  8. Cash J. D., Allan A. G. Effect of mental stress on the fibrinolytic reactivity to exercise. Br Med J. 1967 May 27;2(5551):545–548. doi: 10.1136/bmj.2.5551.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cash J. D., Allan A. G. The fibrinolytic response to moderate exercise and intravenous adrenaline in the same subjects. Br J Haematol. 1967 May;13(3):376–383. doi: 10.1111/j.1365-2141.1967.tb08752.x. [DOI] [PubMed] [Google Scholar]
  10. DAVIDSON E., TOMLIN S. The levels of the plasma coagulation factors after trauma and childbirth. J Clin Pathol. 1963 Mar;16:112–114. doi: 10.1136/jcp.16.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DAVIE E. W., RATNOFF O. D. WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. Science. 1964 Sep 18;145(3638):1310–1312. doi: 10.1126/science.145.3638.1310. [DOI] [PubMed] [Google Scholar]
  12. Davies J. W., Ricketts C. R., Bull J. P. Studies of plasma protein metabolism. 3. Fibrinogen in burned patients. Clin Sci. 1966 Apr;30(2):305–314. [PubMed] [Google Scholar]
  13. Deykin D., Cochios F., DeCamp G., Lopez A. Hepatic removal of activated factor X by the perfused rabbit liver. Am J Physiol. 1968 Feb;214(2):414–419. doi: 10.1152/ajplegacy.1968.214.2.414. [DOI] [PubMed] [Google Scholar]
  14. FLUTE P. T. FIBRINOLYSIS IN RELATION TO THROMBOSIS. Ann R Coll Surg Engl. 1965 Apr;36:225–234. [PMC free article] [PubMed] [Google Scholar]
  15. FLUTE P. T. THE ASSESSMENT OF FIBRINOLYTIC ACTIVITY IN THE BLOOD. Br Med Bull. 1964 Sep;20:195–199. doi: 10.1093/oxfordjournals.bmb.a070330. [DOI] [PubMed] [Google Scholar]
  16. FRANZ R. C., KARK A. E., HATHORN M. Postoperative thrombosis and plasma fibrinolytic activity. A comparative study in Africans, Indians, and whites. Lancet. 1961 Jan 28;1(7170):195–197. doi: 10.1016/s0140-6736(61)91369-1. [DOI] [PubMed] [Google Scholar]
  17. Hardaway R. M. Disseminated intravascular coagulation in experimental and clinical shock. Am J Cardiol. 1967 Aug;20(2):161–173. doi: 10.1016/0002-9149(67)90075-6. [DOI] [PubMed] [Google Scholar]
  18. Hardaway R. M., James P. M., Jr, Anderson R. W., Bredenberg C. E., West R. L. Intensive study and treatment of shock in man. JAMA. 1967 Mar 13;199(11):779–790. [PubMed] [Google Scholar]
  19. Hougie C., Denson K. W., Biggs R. A study of the reaction product of factor 8 and factor IX by gel filtration. Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):211–222. [PubMed] [Google Scholar]
  20. IATRIDIS S. G., FERGUSON J. H. Effect of physical exercise on blood clotting and fibrinolysis. J Appl Physiol. 1963 Mar;18:337–344. doi: 10.1152/jappl.1963.18.2.337. [DOI] [PubMed] [Google Scholar]
  21. INGRAM G. I. Increase in antihaemophilic globulin activity following infusion of adrenaline. J Physiol. 1961 Apr;156:217–224. doi: 10.1113/jphysiol.1961.sp006670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. INNES D., SEVITT S. COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS. J Clin Pathol. 1964 Jan;17:1–13. doi: 10.1136/jcp.17.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Iatridis S. G., Iatridis P. G., Ferguson J. H. The role of HF (factor XII) in the pathogenesis of the thrombolytic state induced by venous occlusion. Thromb Diath Haemorrh. 1966 Jul 31;16(1):207–217. [PubMed] [Google Scholar]
  24. Kakkar V. V., Flanc C., Howe C. T., O'Shea M., Flute P. T. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. Br Med J. 1969 Mar 29;1(5647):806–810. doi: 10.1136/bmj.1.5647.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. LACK C. H., ALI S. Y. TISSUE ACTIVATOR OF PLASMINOGEN. Nature. 1964 Mar 7;201:1030–1031. doi: 10.1038/2011030a0. [DOI] [PubMed] [Google Scholar]
  26. LAKI K., GLADNER J. A. CHEMISTRY AND PHYSIOLOGY OF THE FIBRINOGEN-FIBRIN TRANSITION. Physiol Rev. 1964 Apr;44:127–160. doi: 10.1152/physrev.1964.44.2.127. [DOI] [PubMed] [Google Scholar]
  27. Lipiński B., Worowski K. Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test. Thromb Diath Haemorrh. 1968 Nov 15;20(1):44–49. [PubMed] [Google Scholar]
  28. MACFARLANE R. G. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. Nature. 1964 May 2;202:498–499. doi: 10.1038/202498a0. [DOI] [PubMed] [Google Scholar]
  29. MERSKEY C., JOHNSON A. J., PERT J. H., WOHL H. PATHOGENESIS OF FIBRINOLYSIS IN DEFIBRINATION SYNDROME: EFFECT OF HEPARIN ADMINISTRATION. Blood. 1964 Dec;24:701–715. [PubMed] [Google Scholar]
  30. Menon I. S., Weightman D., Dewar H. A. The role of the lung in blood fibrinolysis. Clin Sci. 1969 Jun;36(3):427–433. [PubMed] [Google Scholar]
  31. Merskey C. Diagnosis and treatment of intravascular coagulation. Br J Haematol. 1968 Dec;15(6):523–526. doi: 10.1111/j.1365-2141.1968.tb01574.x. [DOI] [PubMed] [Google Scholar]
  32. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  33. Merskey C., Lalezari P., Johnson A. J. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med. 1969 Jul;131(3):871–875. doi: 10.3181/00379727-131-33998. [DOI] [PubMed] [Google Scholar]
  34. NIEWIAROWSKI S., PROU-WARTELLE O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thromb Diath Haemorrh. 1959 Sep 1;3:593–603. [PubMed] [Google Scholar]
  35. Nordstrm S., Zetterqvist E. Effects of epsilon aminocaproic acid (EACA) and Trasylol on thromboplastin-induced intravascular coagulation, studied in dogs with iodine-labelled fibrinogen. Acta Physiol Scand. 1969 May-Jun;76(1):93–105. doi: 10.1111/j.1748-1716.1969.tb04454.x. [DOI] [PubMed] [Google Scholar]
  36. Nordström S., Blombäck M., Olsson P., Zetterqvist E. Experimental investigations with proteinase inhibitors. Acta Chir Scand Suppl. 1967;378:33–40. [PubMed] [Google Scholar]
  37. Nossel H. L., Rubin H., Drillings M., Hsieh R. Inhibition of Hageman factor activation. J Clin Invest. 1968 May;47(5):1172–1180. doi: 10.1172/JCI105806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ogston D., Ogston C. M., Ratnoff O. D., Forbes C. D. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest. 1969 Oct;48(10):1786–1801. doi: 10.1172/JCI106145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. PHILLIPS L. L., MALM J. R., DETERLING R. A., Jr Coagulation defects following extracorporeal circulation. Ann Surg. 1963 Mar;157:317–326. doi: 10.1097/00000658-196303000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Penick G. D., Dejanov I. I., Reddick R. L., Roberts H. R. Predisposition to intravascular coagulation. Thromb Diath Haemorrh Suppl. 1966;21:543–554. [PubMed] [Google Scholar]
  41. Penick G. D., Roberts H. R., Dejanov I. I. Covert intravascular clotting. Fed Proc. 1965 Jul-Aug;24(4):835–839. [PubMed] [Google Scholar]
  42. Pitney W. R., Bell W. R., Bolton G. Blood fibrinolytic activity during arvin therapy. Br J Haematol. 1969 Jan-Feb;16(1):165–171. doi: 10.1111/j.1365-2141.1969.tb00389.x. [DOI] [PubMed] [Google Scholar]
  43. Prentice C. R., McNicol G. P., Douglas A. S. Plasminogen activation and the coagulation process. J Clin Pathol. 1969 May;22(3):367–368. doi: 10.1136/jcp.22.3.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. RAPAPORT S. I., SCHIFFMAN S., PATCH M. J., AMES S. B. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood. 1963 Feb;21:221–236. [PubMed] [Google Scholar]
  45. Ratnoff O. D. Epsilon aminocaproic acid--a dangerous weapon. N Engl J Med. 1969 May 15;280(20):1124–1125. doi: 10.1056/NEJM196905152802011. [DOI] [PubMed] [Google Scholar]
  46. Regoeczi E., Gergely J., McFarlane A. S. In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I. J Clin Invest. 1966 Jul;45(7):1202–1212. doi: 10.1172/JCI105426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Replogle R. L. The nature of blood sludging, and its relationship to the pathophysiological mechanisms of trauma and shock. J Trauma. 1969 Aug;9(8):675–683. doi: 10.1097/00005373-196908000-00005. [DOI] [PubMed] [Google Scholar]
  48. SHAINOFF J. R., PAGE I. H. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med. 1962 Nov 1;116:687–707. doi: 10.1084/jem.116.5.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. SHARP A. A., EGGLETON M. J. HAEMATOLOGY AND THE EXTRACORPOREAL CIRCULATION. J Clin Pathol. 1963 Nov;16:551–557. doi: 10.1136/jcp.16.6.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. SPAET T. H. Studies on the in vivo behavior of blood coagulation product I in rats. Thromb Diath Haemorrh. 1962 Nov 15;8:276–285. [PubMed] [Google Scholar]
  51. Sherry S. Fibrinolysis. Annu Rev Med. 1968;19:247–268. doi: 10.1146/annurev.me.19.020168.001335. [DOI] [PubMed] [Google Scholar]
  52. Straub P. W., Riedler G., Frick P. G. Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by haparin. J Clin Pathol. 1967 Mar;20(2):152–157. doi: 10.1136/jcp.20.2.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Summaria L., Hsieh B., Robbins K. C. The specific mechanism of activation of human plasminogen to plasmin. J Biol Chem. 1967 Oct 10;242(19):4279–4283. [PubMed] [Google Scholar]
  54. VERSTRAETE M., AMERY A., VERMYLEN C., ROBYN G. Heparin treatment of bleeding. Lancet. 1963 Feb 23;1(7278):446–446. doi: 10.1016/s0140-6736(63)92340-7. [DOI] [PubMed] [Google Scholar]
  55. VON FRANCKEN I., JOHANSSON L., OLSSON P., ZETTERQVIST E. Heparin treatment of bleeding. Clinical observations. Lancet. 1963 Jan 12;1(7272):70–73. doi: 10.1016/s0140-6736(63)91080-8. [DOI] [PubMed] [Google Scholar]
  56. WARREN B. A. FIBRIONLYTIC ACTIVITY OF VASCULAR ENDOTHELIUM. Br Med Bull. 1964 Sep;20:213–214. doi: 10.1093/oxfordjournals.bmb.a070334. [DOI] [PubMed] [Google Scholar]
  57. WESSLER S., FREIMAN D. G., SUYEMOTO J., REIMER S. M. Serum thrombotic accelerator (STA) activity: a possible key to massive venous thromboembolism in man. Trans Assoc Am Physicians. 1961;74:111–117. [PubMed] [Google Scholar]
  58. Wessler S., Yin E. T. Experimental hypercoagulable state induced by factor X: comparison of the nonactivated and activated forms. J Lab Clin Med. 1968 Aug;72(2):256–260. [PubMed] [Google Scholar]
  59. Wessler S., Yin E. T., Gaston L. W., Nicol I. A distinction between the role of precursor and activated forms of clotting factors in the genesis of stasis thrombi. Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):12–23. [PubMed] [Google Scholar]
  60. Wessler S., Yin E. T. On the mechanism of thrombosis. Prog Hematol. 1969;6:201–232. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES